Prime

Type your tag names separated by a space and hit enter

Dietary factors that promote or retard inflammation.

Abstract

Inflammation plays a pivotal role in all stages of atherosclerosis. Cardiovascular risk factors and metabolic syndrome are typified by low-grade inflammation. Intervention trials convincingly demonstrate that weight loss reduces biomarkers of inflammation, such as C-reactive protein (CRP) and interleukin (IL)-6. Limited studies have shown that certain dietary factors; oleic acid, alpha-linolenic acid, and antioxidants RRR-alpha-alpha tocopherol, reduce biomarkers of inflammation. Most of the studies with fish oil supplementation have shown null effects, and conflicting results have been reported with saturated and trans fatty acids, cholesterol, and soy intake. Much further research is needed to define the role of individual dietary factors on the biomarkers of inflammation and the mechanism of the anti-inflammatory effects of weight loss.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, CA 95817, USA.

    ,

    Source

    MeSH

    Animals
    Biomarkers
    C-Reactive Protein
    Cholesterol, Dietary
    Diet
    Dietary Carbohydrates
    Dietary Fats
    Dietary Fiber
    Dietary Proteins
    Energy Intake
    Humans
    Inflammation
    Interleukin-6
    Weight Loss

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Review

    Language

    eng

    PubMed ID

    16484595

    Citation

    TY - JOUR T1 - Dietary factors that promote or retard inflammation. AU - Basu,Arpita, AU - Devaraj,Sridevi, AU - Jialal,Ishwarlal, Y1 - 2006/02/16/ PY - 2006/2/18/pubmed PY - 2006/5/13/medline PY - 2006/2/18/entrez SP - 995 EP - 1001 JF - Arteriosclerosis, thrombosis, and vascular biology JO - Arterioscler. Thromb. Vasc. Biol. VL - 26 IS - 5 N2 - Inflammation plays a pivotal role in all stages of atherosclerosis. Cardiovascular risk factors and metabolic syndrome are typified by low-grade inflammation. Intervention trials convincingly demonstrate that weight loss reduces biomarkers of inflammation, such as C-reactive protein (CRP) and interleukin (IL)-6. Limited studies have shown that certain dietary factors; oleic acid, alpha-linolenic acid, and antioxidants RRR-alpha-alpha tocopherol, reduce biomarkers of inflammation. Most of the studies with fish oil supplementation have shown null effects, and conflicting results have been reported with saturated and trans fatty acids, cholesterol, and soy intake. Much further research is needed to define the role of individual dietary factors on the biomarkers of inflammation and the mechanism of the anti-inflammatory effects of weight loss. SN - 1524-4636 UR - https://www.unboundmedicine.com/medline/citation/16484595/full_citation L2 - http://www.ahajournals.org/doi/full/10.1161/01.ATV.0000214295.86079.d1?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed ER -